Aim Bulletin
Ixico warns on 2024 revenue amid contract delays
Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked by extended contracting cycles and delays in securing certain new contracts.
Quantum Blockchain reveals new mining method, warns of porting difficulties
Quantum Blockchain Technologies shares were in the red on Wednesday afternoon, after it issued an update on its research and development endeavours in advancing Bitcoin mining technologies.
OptiBiotix signs partnership with India's Dr Morepen
Life science company OptiBiotix Health announced the signing of a partnership agreement with Dr Morepen on Wednesday, for the distribution of SlimBiome products in India under the Dr Morepen brand.
Vast Resources inks new offtake deal with Trafigura
Vast Resources announced a new exclusive offtake agreement with Trafigura Group on Wednesday, for all copper concentrate produced at the Baita Plai Polymetallic Mine in Romania.
Anglesey Mining reports fresh assays from Northern Copper Zone
Anglesey Mining reported assay results from drill hole NCZ002 on Wednesday, marking a significant development in its infill drilling programme at the Northern Copper Zone (NCZ) and Garth Daniel Zone (GDZ) within the Parys Mountain project on the Isle of Anglesey in north west Wales.
AMS reports higher revenue and lower profit, proposes fresh acquisition
Advanced Medical Solutions unveiled its unaudited preliminary results for 2023 on Wednesday, alongside a significant acquisition announcement.
Victoria sees some positive signs in subdued market
Flooring company Victoria said in a trading update on Wednesday that, despite ongoing challenges in the market, it was seeing signs of improvement in the medium-term macroeconomic outlook, particularly in flooring demand indicators.
MaxCyte reports strong fourth quarter as full-year revenues fall
Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15. 7m on Wednesday, up 26% on the same period in 2022.
MusicMagpie FY pre-tax losses widen, reports strong Q1 trading
Online retailer MusicMagpie said on Wednesday that pre-tax losses had widened in the 12 months ended 30 November 2023 but said it "remains confident" about future prospects following strong trading in the first quarter of the new trading year.
Faron Pharmaceuticals reports year of clinical progress
Clinical-stage biopharmaceutical company Faron Pharmaceuticals reported a year of strong progress on Wednesday, with significant overall response rates seen in both previously hypomethylating agent (HMA)-failed and higher-risk myelodysplastic syndrome (MDS) patient populations in the phase one part of the BEXMAB study.
Keywords Studios posts strong growth despite tougher market
Keywords Studios reported a 13% rise in full-year revenue in its final results on Wednesday, to €780m.